Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Pablo Tamayo et al.|Nature|2009Cited by 4.2k
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M. Johannessen, Levi A. Garraway, Ozan Alkan et al.|Nature|2010Cited by 1.4k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumorsLauren L Campbell Marotta, Kornélia Polyák, Vanessa Almendro et al.|Journal of Clinical Investigation|2011Cited by 928
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Samuel Singer, Barry S. Taylor et al.|Nature Genetics|2010Cited by 725
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J. Aguirre, William C. Hahn, Robin M. Meyers et al.|Cancer Discovery|2016Cited by 632